MedPath

Investigation the Effect of Active Vision Therapy Using Vision Therapy System 4 (VTS4) in Bilateral Refractive Amblyopia

Not Applicable
Conditions
amblyopia, lazy eye.
Refractive amblyopia, bilateral,
H53.023
Registration Number
IRCT20230823059229N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Full patient consent to participate in the study
The minimum age is 5 and the maximum is 13 years
Bilateral refractive amblyopes
Astigmatism more than 1.5 diopters and hyperopia more than 3.00 diopters in each eye or a mix hyperopia-stigmatism
Maximum vision 20/40 and minimum vision 20/100 in each eye (moderate amblyopia)

Exclusion Criteria

Children who do not cooperate to perform the tests
Children who experience diplopia or nausea while using liquid crystal glasses
The presence of uncompensated phoria
Children who do not have the necessary follow-up for treatment.
The existence of pathological and structural problems of the eye
History of eye surgeries
The presence of nystagmus
strabismus, microtropia or eccentric fixation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual acuity. Timepoint: before and after. Method of measurement: snellen vision chart LCD chart vision (model, HDC-9000N/PF, made in South Korea) Howitz company.;Stereoacuity. Timepoint: before and after. Method of measurement: Randot &; Vectogram Registered trade marks of Stereo Optical Co., Inc and Stereo Fly Stereotest of Stereo Optical Company Inc.;Contrast sensitivity. Timepoint: before and after. Method of measurement: Freiburg contrast sensitivity test, made in Germany, designed by Michael Bach, 2011 version.;Infacility of Accommodation. Timepoint: Before and after. Method of measurement: flipper lens and snellen near chart.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath